IN8bio, Inc. (INAB)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.6800 |
| Open | 1.5000 |
| Bid | 1.0500 x 100 |
| Ask | 1.1300 x 100 |
| Day's range | 1.0700 - 1.5000 |
| 52-week range | 0.6500 - 2.4800 |
| Volume | |
| Avg. volume | 496,909 |
| Market cap | 48.095M |
| Beta (5Y monthly) | 0.14 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Barrons.com
IN8bio Decline After Favorable Leukemia Results Could Be Profit-Taking
IN8bio shares fall 29% to $1.20 despite favorable data from a Phase 1 leukemia study. Mizuho analysts Uy Ear and Leo Watson are "surprised" by the sell-off and "believe it's overdone, particularly after yesterday's better-than-expected one-year INB-100 data.
© 2024 Yahoo. All rights reserved.